Works matching DE "DACARBAZINE"

Results: 585

Exploring Brazilian Green Propolis Phytochemicals in the Search for Potential Inhibitors of B-Raf 600 E Enzyme: A Theoretical Approach.

Published in:

Pharmaceuticals (14248247), 2025, v. 18, n. 6, p. 902, doi. 10.3390/ph18060902

By:

de Souza, Garcia Ferreira;
Santana, Airis Farias;
Antunes, Fernanda Sanches Kuhl;
Cogo, Ramon Martins;
Pereira, Matheus Dornellas;
Rando, Daniela Gonçales Galasse;
Gonçalves, Carolina Passarelli

Publication type:

Article

Current Reality of Treating Advanced Soft Tissue Sarcoma as Illustrated by Case Studies.

Published in:

Oncology, 2021, v. 99, p. 8, doi. 10.1159/000515366

By:

Broto, Javier Martín;
Jones, Robin L.

Publication type:

Article

Making the Best of Available Options for Optimal Sarcoma Treatment.

Published in:

Oncology, 2018, v. 95, p. 11, doi. 10.1159/000494861

By:

Le Cesne, Axel

Publication type:

Article

A rare paraneoplastic condition in Hodgkin lymphoma: Evans syndrome and literature review.

Published in:

Northern Clinics of Istanbul, 2024, v. 11, n. 5, p. 488, doi. 10.14744/nci.2022.66742

By:

Atas, Unal;
Cerci, Kubra;
Tuncer, Sema;
Karakus, Volkan

Publication type:

Article

Kojic acid derivatives as potential anticancer agents: Synthesis and cytotoxic evaluation on A375 human malignant melanoma cells.

Published in:

Journal of Research in Pharmacy, 2019, v. 23, n. 4, p. 596, doi. 10.12991/jrp.2019.167

By:

KARAKAYA, Gülşah;
ERCAN, Ayşe;
ÖNCÜL, Selin;
AYTEMİR, Mutlu Dilsiz

Publication type:

Article

THE INCREASE IN THE PHOTODYNAMIC POTENTIAL OF DACARBAZINE AS A RESULT OF PH DEPENDENCE.

Published in:

Lucrari Stiintifice: Seria Medicina Veterinara, 2021, v. 64, n. 2, p. 23

By:

COMAN, Ana-Maria;
FUMĂREL, Radu;
BUDAŞCU, Valentin;
ALEXANDRU, Diana Mihaela

Publication type:

Article

Melatonin and Metformin Failed to Modify the Effect of Dacarbazine in Melanoma.

Published in:

Oncologist, 2021, v. 26, n. 5, p. 364, doi. 10.1002/onco.13761

By:

Novik, Aleksei Viktorovich;
Protsenko, Svetlana Anatolievna;
Baldueva, Irina Alexandrovna;
Berstein, Lev Michailovich;
Anisimov, Vladimir Nikolaevich;
Zhuk, Irina Nikolaevna;
Semenova, Anna Igorevna;
Latipova, Dilorom Khamidovna;
Tkachenko, Elena Viktorovna;
Semiglazova, Tatiana Yurievna

Publication type:

Article

A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath Tumors.

Published in:

Oncologist, 2019, v. 24, n. 6, p. 857, doi. 10.1634/theoncologist.2018-0160

By:

D'Adamo, David R.;
Dickson, Mark A.;
Keohan, Mary L.;
Carvajal, Richard D.;
Hensley, Martee L.;
Hirst, Catherine M.;
Ezeoke, Marietta O.;
Ahn, Linda;
Qin, Li‐Xuan;
Antonescu, Cristina R.;
Lefkowitz, Robert A.;
Maki, Robert G.;
Schwartz, Gary K.;
Tap, William D.

Publication type:

Article

Gemcitabine Plus Docetaxel, Dacarbazine, Doxorubicin Combinations, or Doxorubicin Alone as First-Line Treatment for Advanced/Metastatic Leiomyosarcoma: A Retrospective Analysis at a Sarcoma Center.

Published in:

Diseases, 2025, v. 13, n. 3, p. 79, doi. 10.3390/diseases13030079

By:

Kim, Ted;
Hao, Clara;
Pan, Minggui;
Ganjoo, Kristen N.;
Bui, Nam Q.

Publication type:

Article

Antioxidant, Enzyme, and H 2 O 2 -Triggered Melanoma Targeted Mesoporous Organo-Silica Nanocomposites for Synergistic Cancer Therapy.

Published in:

Antioxidants, 2022, v. 11, n. 11, p. 2137, doi. 10.3390/antiox11112137

By:

Choi, Hyung Woo;
Lim, Jae Hyun;
Kang, Taewook;
Chung, Bong Geun

Publication type:

Article

In vitro Cytotoxic Activity of Extracts from Barrientosiimonas humi on Cancer Cell Lines.

Published in:

Malaysian Journal of Medicine & Health Sciences, 2017, v. 13, p. 9

By:

Cheah Yoke Kqueen;
Yeoh Chiann Ying;
Rosandy, Andi Rifki;
Khalid, Rozida

Publication type:

Article

Molecular docking and physicochemical studies of 1,3-benzodioxole tagged Dacarbazine derivatives as an anticancer agent.

Published in:

Artificial Cells, Nanomedicine & Biotechnology, 2023, v. 51, n. 1, p. 520, doi. 10.1080/21691401.2023.2253470

By:

Kharb, Sonaxi;
Yadav, Sangeeta;
Singh, Anshul;
Sarkar, Anjana;
Tomar, Ravi

Publication type:

Article

NIR triggered glycosylated gold nanoshell as a photothermal agent on melanoma cancer cells.

Published in:

Artificial Cells, Nanomedicine & Biotechnology, 2019, v. 47, n. 1, p. 2316, doi. 10.1080/21691401.2019.1593187

By:

Nouri, Samira;
Mohammadi, Elham;
Mehravi, Bita;
Majidi, Fatemehsadat;
Ashtari, Khadijeh;
Neshasteh-Riz, Ali;
Einali, Samira

Publication type:

Article

Magnetic core mesoporous silica nanoparticles doped with dacarbazine and labelled with 99mTc for early and differential detection of metastatic melanoma by single photon emission computed tomography.

Published in:

Artificial Cells, Nanomedicine & Biotechnology, 2018, v. 46, p. 1080, doi. 10.1080/21691401.2018.1443941

By:

Portilho, Filipe Leal;
Helal-Neto, Edward;
Cabezas, Santiago Sánchez;
Pinto, Suyene Rocha;
dos Santos, Sofia Nascimento;
Pozzo, Lorena;
Sancenón, Félix;
Martínez-Máñez, Ramón;
Santos-Oliveira, Ralph

Publication type:

Article

Magnetic core mesoporous silica nanoparticles doped with dacarbazine and labelled with 99mTc for early and differential detection of metastatic melanoma by single photon emission computed tomography.

Published in:

Artificial Cells, Nanomedicine & Biotechnology, 2018, v. 46, p. 1080, doi. 10.1080/21691401.2018.1443941

By:

Portilho, Filipe Leal;
Helal-Neto, Edward;
Cabezas, Santiago Sánchez;
Pinto, Suyene Rocha;
dos Santos, Sofia Nascimento;
Pozzo, Lorena;
Sancenón, Félix;
Martínez-Máñez, Ramón;
Santos-Oliveira, Ralph

Publication type:

Article

Melittin derived peptide-drug conjugate, M-DM1, inhibits tumor progression and induces effector cell infiltration in melanoma by targeting M2 tumor-associated macrophages.

Published in:

Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1178776

By:

Chanmi Jeong;
Jeongdong Kim;
Ik-Hwan Han;
Soyoung Kim;
Ilseob Choi;
Hongsung Kim;
Jin-Hyun Jeong;
Hyunsu Bae

Publication type:

Article

Checkpoint inhibitor-induced eosinophilic fasciitis following high eosinophilia associated with complete response.

Published in:

2019

By:

Toussaint, Frédéric;
Hammon, Matthias;
Erdmann, Michael;
Moreira, Alvaro;
Kirchberger, Michael C;
Schuler, Gerold;
Schett, Georg;
Heinzerling, Lucie

Publication type:

Case Study

Adjuvant therapy with low-dose interferon-beta for stage II and III melanoma: results of a retrospective analysis.

Published in:

Clinical & Experimental Dermatology, 2017, v. 42, n. 7, p. 781, doi. 10.1111/ced.13179

By:

Yanagi, T.;
Hata, H.;
Homma, E.;
Kitamura, S.;
Imafuku, K.;
Shimizu, H.

Publication type:

Article

Prospective assessment of circulating tumor DNA in patients with metastatic uveal melanoma treated with tebentafusp.

Published in:

Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-53145-0

By:

Rodrigues, Manuel;
Ramtohul, Toulsie;
Rampanou, Aurore;
Sandoval, José Luis;
Houy, Alexandre;
Servois, Vincent;
Mailly-Giacchetti, Léah;
Pierron, Gaelle;
Vincent-Salomon, Anne;
Cassoux, Nathalie;
Mariani, Pascale;
Dutriaux, Caroline;
Pracht, Marc;
Ryckewaert, Thomas;
Kurtz, Jean-Emmanuel;
Roman-Roman, Sergio;
Piperno-Neumann, Sophie;
Bidard, François-Clément;
Stern, Marc-Henri;
Renault, Shufang

Publication type:

Article

Management of Hodgkin's lymphoma in Latin America.

Published in:

Journal of Alternative Medicine Research, 2019, v. 11, n. 4, p. 389

By:

Ferrigno, Lívia Alvarenga Fagundes;
Marta, Gustavo Nader;
Lim, Fiona;
Wan, Bo Angela;
Silva, Mauricio F.

Publication type:

Article

Successful Response to Cyclophosphamide, Vincristine, and Dacarbazine Chemotherapy in a Patient with Metastatic Carotid Body Paraganglioma.

Published in:

2021

By:

Yamada, Hiroki;
Fukushima, Toshirou;
Kobayashi, Takashi;
Kanda, Shintaro;
Koizumi, Tomonobu;
Iwaya, Mai

Publication type:

Case Study

An in vitro Study for the Synergistic Cytotoxic Actions of Biological Therapy and Anticancer Chemotherapy.

Published in:

Indian Journal of Forensic Medicine & Toxicology, 2019, v. 13, n. 3, p. 237, doi. 10.5958/0973-9130.2019.00202.0

By:

Obayes, Sarah K.;
Obied, Hamid Naji;
Al-Saadi, Mohammed A. K.

Publication type:

Article

Immunoregulatory protein B7-H3 promotes growth and decreases sensitivity to therapy in metastatic melanoma cells.

Published in:

Pigment Cell & Melanoma Research, 2017, v. 30, n. 5, p. 467, doi. 10.1111/pcmr.12599

By:

Flem ‐ Karlsen, Karine;
Tekle, Christina;
Andersson, Yvonne;
Flatmark, Kjersti;
Fodstad, Øystein;
Nunes ‐ Xavier, Caroline E.

Publication type:

Article

Permanent dose reduction due to adverse reactions does not decrease efficacy of BRAF/MEK inhibition in metastatic melanoma.

Published in:

Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 5, p. e605, doi. 10.1111/jdv.18871

By:

Buchacher, Lukas;
Richtig, Georg;
Dernoscheg, Marie;
Richtig, Erika;
Koch, Lukas

Publication type:

Article

Health‐related quality of life trajectories in melanoma patients after electrochemotherapy: real‐world insights from the InspECT register.

Published in:

Journal of the European Academy of Dermatology & Venereology, 2022, v. 36, n. 12, p. 2352, doi. 10.1111/jdv.18456

By:

Campana, L.G.;
Quaglino, P.;
de Terlizzi, F.;
Mascherini, M.;
Brizio, M.;
Spina, R.;
Bertino, G.;
Kunte, C.;
Odili, J.;
Matteucci, P.;
MacKenzie Ross, A.;
Schepler, H.;
Clover, J.A.P.;
Kis, E.;
Bechara, F.;
Giorgione, R.;
Mowatt, D.;
Orlando, A.;
Pecorari, G.;
Pritchard Jones, R.

Publication type:

Article

PERSONALISED THERAPY FOR MELANOMA.

Published in:

Rad Hrvatske Akademije Znanosti i Umjetnosti. Medicinske Znanosti, 2014, v. 520, n. 40, p. 51

By:

Broziĉ, Jasmina Mariĉ;
Ðakoviĉ, Nikola

Publication type:

Article

Successful use of equine anti-thymocyte globulin (ATGAM) for fulminant myocarditis secondary to nivolumab therapy.

Published in:

2017

By:

Tay, Rebecca Y;
Blackley, Elizabeth;
McLean, Catriona;
Moore, Maggie;
Bergin, Peter;
Gill, Sanjeev;
Haydon, Andrew

Publication type:

journal article

CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells.

Published in:

2017

By:

Maciaczyk, D;
Picard, D;
Zhao, L;
Koch, K;
Herrera-Rios, D;
Li, G;
Marquardt, V;
Pauck, D;
Hoerbelt, T;
Zhang, W;
Ouwens, D M;
Remke, M;
Jiang, T;
Steiger, H J;
Maciaczyk, J;
Kahlert, U D

Publication type:

journal article

Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling.

Published in:

2017

By:

Han, Sheng;
Meng, Lingxuan;
Jiang, Yang;
Cheng, Wen;
Tie, Xinxin;
Xia, Junzhe;
Wu, Anhua

Publication type:

journal article

A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation.

Published in:

2017

By:

Calegari, M A;
Inno, A;
Monterisi, S;
Orlandi, A;
Santini, D;
Basso, M;
Cassano, A;
Martini, M;
Cenci, T;
de Pascalis, I;
Camarda, F;
Barbaro, B;
Larocca, L M;
Gori, S;
Tonini, G;
Barone, C

Publication type:

journal article

Therapeutic interactions of autophagy with radiation and temozolomide in glioblastoma: evidence and issues to resolve.

Published in:

2016

By:

Koukourakis, Michael I;
Mitrakas, Achilleas G;
Giatromanolaki, Alexandra

Publication type:

journal article

Non-thermal atmospheric plasma induces ROS-independent cell death in U373MG glioma cells and augments the cytotoxicity of temozolomide.

Published in:

2016

By:

Conway, Gillian E;
Casey, Alan;
Milosavljevic, Vladimir;
Liu, Yupeng;
Howe, Orla;
Cullen, Patrick J;
Curtin, James F

Publication type:

journal article

Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant.

Published in:

2016

By:

Zakaria, Z;
Tivnan, A;
Flanagan, L;
Murray, D W;
Salvucci, M;
Stringer, B W;
Day, B W;
Boyd, A W;
Kögel, D;
Rehm, M;
O'Brien, D F;
Byrne, A T;
Prehn, J H M;
Kögel, D

Publication type:

journal article

Exogenous IGFBP-2 promotes proliferation, invasion, and chemoresistance to temozolomide in glioma cells via the integrin β1-ERK pathway.

Published in:

2014

By:

Han, S;
Li, Z;
Master, L M;
Master, Z W;
Wu, A

Publication type:

journal article

Inhibition of DNA repair with MGMT pseudosubstrates: phase I study of lomeguatrib in combination with dacarbazine in patients with advanced melanoma and other solid tumours.

Published in:

2011

By:

Tawbi, H. A.;
Villaruz, L.;
Tarhini, A.;
Moschos, S.;
Sulecki, M.;
Viverette, F.;
Shipe-Spotloe, J.;
Radkowski, R.;
Kirkwood, J. M.

Publication type:

journal article

Central nervous system failure in melanoma patients: results of a randomised, multicentre phase 3 study of temozolomide- and dacarbazine- based regimens.

Published in:

2011

By:

Chiarion-Sileni, V.;
Guida, M.;
Ridolfi, L.;
Romanini, A.;
Del Bianco, P.;
Pigozzo, J.;
Brugnara, S.;
Colucci, G.;
Ridolfi, R.;
De Salvo, G. L.;
Italian Melanoma Intergroup (IMI)

Publication type:

journal article

Predicting the outcome of grade II glioma treated with temozolomide using proton magnetic resonance spectroscopy.

Published in:

2011

By:

Guillevin, R.;
Menuel, C.;
Taillibert, S.;
Capelle, L.;
Costalat, R.;
Abud, L.;
Habas, C.;
De Marco, G.;
Hoang-Xuan, K.;
Chiras, J.;
Vallée, J.-N.;
Vallée, J-N

Publication type:

journal article

Early toxicity predicts long-term survival in high-grade glioma.

Published in:

2011

By:

Lawrence, Y R;
Wang, M;
Dicker, A P;
Andrews, D;
Curran, W J;
Michalski, J M;
Souhami, L;
Yung, W-Ka;
Mehta, M;
Curran, W J Jr

Publication type:

journal article

A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours.

Published in:

2011

By:

Khan, O. A.;
Gore, M.;
Lorigan, P.;
Stone, J.;
Greystoke, A.;
Burke, W.;
Carmichael, J.;
Watson, A. J.;
McGown, G.;
Thorncroft, M.;
Margison, G. P.;
Califano, R.;
Larkin, J.;
Wellman, S.;
Middleton, M. R.

Publication type:

journal article

Central nervous system penetration and enhancement of temozolomide activity in childhood medulloblastoma models by poly(ADP-ribose) polymerase inhibitor AG-014699.

Published in:

2010

By:

Daniel, R. A.;
Rozanska, A. L.;
Mulligan, E. A.;
Drew, Y.;
Thomas, H. D.;
Castelbuono, D. J.;
Hostomsky, Z.;
Plummer, E. R.;
Tweddle, D. A.;
Boddy, A. V.;
Clifford, S. C.;
Curtin, N. J.

Publication type:

journal article

Activity of irinotecan and temozolomide in the presence of O6-methylguanine-DNA methyltransferase inhibition in neuroblastoma pre-clinical models.

Published in:

2010

By:

Cai, W.;
Maldonado, N. V.;
Cui, W.;
Harutyunyan, N.;
Ji, L.;
Sposto, R.;
Reynolds, C. P.;
Keshelava, N.

Publication type:

journal article

Combination of temozolomide with immunocytokine F16-IL2 for the treatment of glioblastoma.

Published in:

2010

By:

Pedretti, M.;
Verpelli, C.;
M&;#x00E5;rlind, J.;
Bertani, G.;
Sala, C.;
Neri, D.;
Bello, L.;
Mårlind, J

Publication type:

journal article

MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome.

Published in:

2010

By:

Hassel, J. C.;
Sucker, A.;
Edler, L.;
Kurzen, H.;
Moll, I.;
Stresemann, C.;
Spieth, K.;
Mauch, C.;
Rass, K.;
Dummer, R.;
Schadendorf, D.

Publication type:

journal article

Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide.

Published in:

2010

By:

van Nifterik, K. A.;
van den Berg, J.;
van der Meide, W. F.;
Ameziane, N.;
Wedekind, L. E.;
Steenbergen, R. D. M.;
Leenstra, S.;
Lafleur, M. V. M.;
Slotman, B. J.;
Stalpers, L. J. A.;
Sminia, P.

Publication type:

journal article

Pulmonary Langerhans Cell Histiocytosis Post-Hodgkin Lymphoma Completely Resolved With Vinblastine in a Heavy Smoker: Coincidence or Causation?

Published in:

International Journal of Surgical Pathology, 2025, v. 33, n. 1, p. 209, doi. 10.1177/10668969241253216

By:

Shaker, Nada;
Shaker, Nuha;
Abu Shakra, Rafat;
Yenwongafi, Leonard;
Pradhan, Dinesh;
Sangueza, Omar P.

Publication type:

Article

Distribution of Tattoo Pigment in Lymph Nodes Dissected for Gynecological Malignancy.

Published in:

International Journal of Surgical Pathology, 2019, v. 27, n. 7, p. 773, doi. 10.1177/1066896919846395

By:

Tamura, Daisuke;
Maeda, Daichi;
Terada, Yukihiro;
Goto, Akiteru

Publication type:

Article

The efficacy and safety of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor, in patients with advanced head and neck mucosal melanoma harboring CDK4 amplification.

Published in:

BMC Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12916-024-03431-x

By:

Shi, Chaoji;
Ju, Houyu;
Zhou, Rong;
Xu, Shengming;
Wu, Yunteng;
Gu, Ziyue;
Wang, Ying;
Chen, Wanling;
Huang, Xinyi;
Han, Yong;
Sun, Shuyang;
Li, Chuwen;
Wang, Min;
Zhou, Guoyu;
Zhang, Zhiyuan;
Li, Jiang;
Ren, Guoxin

Publication type:

Article

First-in-human phase I dose-escalation and dose-expansion trial of the selective MEK inhibitor HL-085 in patients with advanced melanoma harboring NRAS mutations.

Published in:

BMC Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12916-022-02669-7

By:

Wang, Xuan;
Luo, Zhiguo;
Chen, Jing;
Chen, Yu;
Ji, Dongmei;
Fan, Li;
Chen, Ling;
Zhao, Qian;
Hu, Pei;
Sun, Peng;
Jia, Zhongwei;
Guo, Jun;
Si, Lu

Publication type:

Article

MicroRNA-195 acts as an anti-proliferative miRNA in human melanoma cells by targeting Prohibitin 1.

Published in:

2017

By:

Ramos Cirilo, Priscila Daniele;
de Sousa Andrade, Luciana Nogueira;
Silva Corrêa, Bruna Renata;
Qiao, Mei;
Furuya, Tatiane Katsue;
Chammas, Roger;
Ferraz Penalva, Luiz Otavio;
Cirilo, Priscila Daniele Ramos;
Corrêa, Bruna Renata Silva;
Penalva, Luiz Otavio Ferraz

Publication type:

journal article

A type I combi-targeting approach for the design of molecules with enhanced potency against BRCA1/2 mutant- and O6-methylguanine-DNA methyltransferase (mgmt)- expressing tumour cells.

Published in:

2017

By:

Mouhri, Zhor Senhaji;
Goodfellow, Elliot;
Jean-Claude, Bertrand;
Senhaji Mouhri, Zhor

Publication type:

journal article